United States - English - NLM (National Library of Medicine)

amersham health inc. - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoate - unii:), diatrizoate sodium (unii: v5403h8vg7) (diatrizoate - unii:) - injection, solution - 660 mg in 1 ml - hypaque-76 is indicated for excretory urography, aortography, angiocardiography (ventriculography, pulmonary angiography, selective coronary arteriography), peripheral angiography (peripheral arteriography and peripheral venography), intravenous digital arteriography, contrast enhancement of computed tomographic head imaging, contrast enhancement of computed tomographic body imaging, selective renal arteriography, selective visceral arteriography, central venography, and renal venography. in addition to the following generalcontraindications, warnings, precautions, and adverse reactions, there are additional listings in these categories under the particular procedures. hypaque-76 has no absolute contraindications in its recommended uses (see general warnings and precautions). do not use hypaque-76 for myelography or for examination of dorsal cysts or sinuses which might communicate with the subarachnoid space. even a small amount in the subarachnoid space may produce convulsions and result in fatality. (see

United States - English - NLM (National Library of Medicine)

amersham health inc. - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 30 g in 100 ml - hypaque-cysto is indicated for retrograde cystourethrography in adult and pediatric patients. hypaque-cysto has no absolute contraindication in its recommended use.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - sodium chromate(51cr) -

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - chromium(51cr) edetate -

Singapore - English - HSA (Health Sciences Authority)

ge healthcare pte. ltd. - sodium molybdate (99mo); sodium pertechnetate (99mtc) - injection - 2.5-100 gbq/generator - sodium molybdate (99mo) 2.5-100 gbq/generator; sodium pertechnetate (99mtc) variable

Canada - English - Health Canada

amersham health inc - diatrizoate meglumine - solution - 18% - diatrizoate meglumine 18% - roentgenography

Canada - English - Health Canada

amersham health inc - diatrizoate meglumine - solution - 30% - diatrizoate meglumine 30% - roentgenography

Canada - English - Health Canada

amersham health inc - diatrizoate meglumine - solution - 60% - diatrizoate meglumine 60% - roentgenography

Canada - English - Health Canada

amersham health inc - diatrizoate sodium; diatrizoate meglumine - solution - 10%; 66% - diatrizoate sodium 10%; diatrizoate meglumine 66% - roentgenography

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

amersham health - iodixanol - solution for injection - 270mg/1ml